Login / Signup

The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database.

In Sil ChoiJiwoong JungByoung Hyuck KimSohee OhJongjin KimJin Hyun ParkJeong Hwan ParkKi-Tae Hwang
Published in: Cancers (2020)
Our findings provide real-world evidence that the 21-gene RS assay is predictive of chemotherapy benefit among patients in clinical practice. More refined risk estimates would be needed for patients with an intermediate RS.
Keyphrases
  • clinical practice
  • high throughput
  • copy number
  • locally advanced
  • genome wide
  • genome wide identification
  • squamous cell carcinoma
  • gene expression
  • rectal cancer
  • transcription factor
  • adverse drug
  • genome wide analysis